SCHEMBL5528384

SCHEMBL5528384

CCn1c(C(CCSC)OCCO)nc(C(=O)O)c(OCc2ccccc2)c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR1 P21462 2/20 0.35
TSHR P16473 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ATM Q13315 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
PTGES O14684 1/20 0.32
ALOX5 P09917 1/20 0.32
USP2 O75604 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA1 P30542 1/20 0.31
FFAR1 O14842 1/20 0.31
MAPK1 P28482 1/20 0.30
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
CACNA2D1 P54289 1/20 0.30
MAPT P10636 2/20 0.30
AAK1 Q2M2I8 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5534568 0.84 TSHR (0.36) TSHRRXFP1ATMNPC1ALDH1A1
SCHEMBL5532745 0.77 MCL1 (0.35) TSHRRXFP1ATMNPC1ALDH1A1
SCHEMBL5526219 0.75 ADORA1 (0.34) TSHRRXFP1ATMALDH1A1ADORA3
SCHEMBL5534178 0.75 TSHR (0.42) TSHRRXFP1ATMALDH1A1KMT2A
SCHEMBL4034705 0.72 GABRA1 (0.35) TSHRNPC1ALDH1A1KMT2AUSP2
SCHEMBL3420229 0.65 CYP1A2 (0.47) TSHRNPC1ALDH1A1KMT2AMAPK1
SCHEMBL4040796 0.64 GRM5 (0.34) ALDH1A1KMT2AMAPT
SCHEMBL2507511 0.64 MAOA (0.48) TSHRALDH1A1KMT2AMAPK1CASP1
SCHEMBL14572114 0.62 KMO (0.39) TSHRALDH1A1FFAR1MAPK1CASP1
SCHEMBL823470 0.62 ELANE (0.41) TSHRALDH1A1KMT2AUSP2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007064316-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-07 WO disclosed
EP-1749011-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2007-02-07 EP disclosed
WO-2005118593-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-15 WO disclosed